普通外文研报
资生堂:F12/26第二季度业绩:利润保持强劲增长
研报英文原文证据摘录
M
Update
August 5, 2026 12:50 PM GMT
Morgan Stanley MUFG Securities Co., Ltd.+
Shiseido (4911) | Japan
Haruka Miyake
Equity Analyst
F12/26 2Q Results: Profits
Maintain Strong Progress
Jully Ussui
Research Associate
AlphaSignals Earnings Reaction
Unchanged
Meaningful upside
Modest revision higher
Impact to our thesis
Financial results versus consensus
Direction of next 12-month
consensus EPS
Source: Company data, Morgan Stanley Research
Key Takeaways
We expect a neutral share price reaction after recent gains, though Shiseido's
comment that Core OP progress versus F12/26 plan is ahead of schedule and that
Shiseido (4911.T, 4911 JT)
Cosmetics & Personal Care Products | Japan
Stock Rating
Industry View
Price target
Shr price, close (Aug 5, 2026)
Mkt cap, curr, basic (bn)
Avg daily trading value (bn)
Equal-weight
In-Line
¥2,900
¥3,269
¥1,306.1
¥9.4
it's eyeing upside is modestly positive.
2Q sales growth improved vs. 1Q, but not enough to be considered a major
Exhibit 1 : Comparison of our forecasts,
surprise. China and TR sales were stronger than we expected.
Shiseido maintained F12/26 guidance. Management cited competition in Western
markets as a risk for 2H sales and plans to make strategic marketing investments
behind new products.
Market expectations for F12/26 Core OP are likely to start climbing, though to
consensus estimates and actual
results
4911.T
2Q25A
2Q26A
2Q26e
F12/25A
just a modest degree given ongoing cost headwinds.
From a mid/long-term perspective, accelerating sales growth remains the more
F12/26e
important issue, and we feel it is still too early to adopt a more constructive
stance.
F12/27e
F12/28e
• Restructuring and productivity improvements are starting to provide benefits
for Shiseido's earnings, which is a marked change from past trends. Our view
bn yen
Actual
MSe
VAe
IFISe
Actual
MSe
CE
VAe
IFISe
MSe
VAe
IFISe
MSe
VAe
IFISe
Sales
241.6
267.0
261.3
258.3
253.7
970.0
1,028.6
990.0
1,009.8
1,003.7
1,070.3
1,043.8
1,034.8
1,107.9
1,077.9
1,067.1
BP
15.1
31.4
17.0
20.9
NA
44.5
64.6
69.0
69.3
NA
77.4
80.5
NA
85.1
89.9
NA
OP
10.9
29.6
13.0
17.6
13.0
-28.8
53.6
59.0
60.6
57.7
66.4
76.7
71.8
74.1
86.4
82.8
NP
5.8
21.3
9.2
12.2
12.4
-40.7
36.0
42.0
…
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器